UPDATE: Syneos Health (SYNH) Tops Q1 EPS by 6c, Offers FY Guidance

Syneos Health (NASDAQ: SYNH) reported Q1 EPS of $1.01, $0.06 better than the analyst estimate of $0.95. Revenue for the quarter came in at $1.34 billion versus the consensus estimate of $1.32 billion.

GUIDANCE:

Syneos Health sees FY2022 EPS of $5.05-$5.25, versus the consensus of $5.08. ObsEva SA sees FY2022 revenue of $5.6-5.75 billion, versus the consensus of $5.65 billion.

For earnings history and earnings-related data on Syneos Health (SYNH) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c